hyoscyamine has been researched along with mestranol in 1 studies
Studies (hyoscyamine) | Trials (hyoscyamine) | Recent Studies (post-2010) (hyoscyamine) | Studies (mestranol) | Trials (mestranol) | Recent Studies (post-2010) (mestranol) |
---|---|---|---|---|---|
99 | 1 | 55 | 2,495 | 183 | 25 |
Protein | Taxonomy | hyoscyamine (IC50) | mestranol (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.018 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.382 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.382 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.041 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
1 other study(ies) available for hyoscyamine and mestranol
Article | Year |
---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |